Key points
- Acne is not caused by “too much” Cutibacterium acnes. Healthy and acne-prone skin carry similar amounts; what differs is the balance of strains[1].
- A loss of C. acnes strain (phylotype) diversity — with certain pro-inflammatory lineages dominating — is linked to the inflammatory process[1].
- This reframes treatment: the aim is to restore strain balance, not to eradicate the species — which is what makes strain-specific bacteriophages interesting[3].
- A phase 1 cosmetic trial of a topical C. acnes phage gel found it safe to apply and able to lower facial C. acnes[2].
The old story was wrong in a useful way
For decades acne was framed as C. acnes running rampant, and treatment meant killing it — hence long courses of antibiotics. The reframing of the last several years is subtle but important: people with and without acne carry comparable overall amounts of C. acnes. The difference is in the strains[1].
Strains, not species
C. acnes comes in distinct lineages called phylotypes. Healthy skin tends to carry a diverse mix; acne-prone skin tends toward a loss of that diversity, with particular pro-inflammatory phylotypes (notably from the IA1 lineage) overrepresented[1]. It is the collapse of strain diversity — a within-species dysbiosis — that associates with the inflammatory cascade, alongside excess sebum, follicular plugging and the immune response to all of it.
| C. acnes total amount | roughly unchanged vs. clear skin |
| C. acnes strain diversity | narrowed |
| Pro-inflammatory phylotypes (e.g. IA1) | overrepresented |
| Protective strain balance | lost |
This is why broad antibiotics can disappoint long-term: they reduce bacteria indiscriminately and drive resistance, without restoring the lost strain balance.
Why this is where phages get interesting
If acne is a strain-balance problem, you want a tool precise enough to act at the strain level — reducing the pro-inflammatory lineages while sparing the protective ones. That is precisely what bacteriophages do: they are often specific to particular strains. Researchers have isolated C. acnes-targeting phages, and a phase 1 cosmetic trial showed a topical phage gel could be applied safely and reduce facial C. acnes[2]. A 2024 review lays out the rationale and the open questions for C. acnes phage therapy as a precision approach[3]. It is early-stage, but it maps cleanly onto the biology.
What you can measure
Whole-genome sequencing of facial skin can resolve not just which species are present but which C. acnes strains dominate — the level that actually matters for acne. That is the information needed to move from “kill bacteria” to “restore balance.”
Common questions
Is acne caused by too much bacteria?
Not in the way it is often described. People with and without acne carry similar overall amounts of Cutibacterium acnes. What differs is the balance of strains: acne-prone skin shows a loss of C. acnes strain diversity with certain pro-inflammatory lineages dominating. So acne is better understood as a within-species imbalance than as simple bacterial overgrowth.
Why don’t antibiotics cure my acne?
Antibiotics reduce bacteria broadly and indiscriminately, but they do not restore the lost balance of protective C. acnes strains — and long use drives antibiotic resistance and disrupts other commensals. They can help during treatment but often disappoint long-term, which is part of why the field is moving toward strain-precise approaches.
Can bacteriophages treat acne?
Phages that specifically target C. acnes are an active research area, and their strain-level precision fits acne’s biology well. A phase 1 cosmetic trial of a topical C. acnes phage gel found it safe to apply and able to reduce facial C. acnes. It is a promising, early-stage frontier rather than an established, broadly approved acne treatment.
What does “strain diversity” mean for my skin?
C. acnes exists as several distinct lineages (phylotypes). Clear skin tends to carry a diverse mix; acne-prone skin tends to lose that diversity, letting pro-inflammatory strains dominate. Strain-level testing can reveal which lineages dominate on your skin — the detail that matters most for acne but that ordinary swabs miss.
Sequence your acne, don’t guess
Acne lives at the strain level, where ordinary tests can’t see. Parallel’s MD-03 Protocol™ uses whole-genome sequencing to resolve your C. acnes strain balance, then formulates a custom serum with a precision phage cocktail aimed at the pathogenic strains it finds.
Explore acne solutions →Offered by Parallel Health, a licensed teledermatology practice. Custom formulations are based on individual assessment; this page is educational, not medical advice.
References
- Dagnelie MA, et al. Cutibacterium acnes phylotypes diversity loss: a trigger for skin inflammatory process. J Eur Acad Dermatol Venereol. 2019;33(12):2340-2348. https://doi.org/10.1111/jdv.15795
- Golembo M, et al. Development of a topical bacteriophage gel targeting Cutibacterium acnes for acne-prone skin: a phase 1 cosmetic randomized clinical trial. Skin Health Dis. 2022;2(2):e93. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168013/
- Mohammadi M, et al. Cutibacterium acnes bacteriophage therapy: exploring a new frontier in acne vulgaris treatment. Arch Dermatol Res. 2024;317(1):84. https://pubmed.ncbi.nlm.nih.gov/39644414/